Researching Emotions And Cardiac Health (REACH): Phase II
REACH II
Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: proof-of Concept Trial
2 other identifiers
interventional
10
1 country
1
Brief Summary
The focus of this study is to examine the feasibility, acceptability, and preliminary impact of our customized positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2016
CompletedFirst Posted
Study publicly available on registry
October 19, 2016
CompletedStudy Start
First participant enrolled
December 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2017
CompletedResults Posted
Study results publicly available
September 19, 2018
CompletedSeptember 1, 2021
August 1, 2021
8 months
October 14, 2016
March 20, 2018
August 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the PP-based Health Behavior Intervention
Feasibility will be measured by examining the number of completed exercises.
10 weeks
Secondary Outcomes (16)
Changes in PANAS Scores
Change in score from Baseline to 10 weeks
Changes in LOT-R Scores
Change of score from Baseline to 10 weeks
Changes in HADS-Anxiety Subscale Scores
Change in score from Baseline to 10 weeks
Change in HADS-Depression Subscale Scores
Change in score from Baseline to 10 weeks
Changes in KCCQ Scores
Change in score from Baseline to 10 weeks
- +11 more secondary outcomes
Study Arms (1)
Intervention Arm
EXPERIMENTALParticipants will all undergo a 10-week PP-based health behavior intervention and adherence measurements (baseline and Week 10). The participants will receive an ActiGraph accelerometer. They will be asked to begin wearing the accelerometer after their initial visit. Participants will wear the ActiGraph for 7 days at baseline and again at 10 weeks.
Interventions
The positive psychology exercises include 3 modules: Gratitude-based activities, Strength-based activities, and Meaning-based activities. The goal setting exercises include 3 modules: Physical activity, Heart-healthy diet, and Medication adherence.
Eligibility Criteria
You may qualify if:
- Adult patients with NYHA class I, II, or III HF admitted to an MGH inpatient unit or outpatients at the MGH Heart Center. Patients with NYHA class IV HF have ongoing HF symptoms at rest, making it difficult for them to increase physical activity and other health behaviors; therefore, they will not be included. HF diagnosis will be confirmed via chart review and with the patient's treatment team as needed.
- Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS SAS) items regarding diet/exercise/medications. The MOS SAS has been used in multiple prior studies assessing adherence in cardiac patients, including our own studies in this population. This threshold score on the MOS SAS will ensure that all participants will have the potential to improve their health behaviors.
You may not qualify if:
- Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test that is sensitive and specific for screening for cognitive impairment in research participants.
- Medical conditions precluding interviews or likely to lead to death within 6 months.
- Inability to speak English, inability to read or write, inability to walk, or lack of a telephone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (1)
Celano CM, Freedman ME, Beale EE, Gomez-Bernal F, Huffman JC. A Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: A Proof-of-Concept Trial. J Nerv Ment Dis. 2018 Oct;206(10):800-808. doi: 10.1097/NMD.0000000000000883.
PMID: 30273277DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Was performed at a single academic medical center and had a largely White population. It was a small sample size and there was no control condition in this initial trial.
Results Point of Contact
- Title
- Dr. Christopher Celano
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher M Celano, MD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant in Psychiatry
Study Record Dates
First Submitted
October 14, 2016
First Posted
October 19, 2016
Study Start
December 6, 2016
Primary Completion
July 24, 2017
Study Completion
August 10, 2017
Last Updated
September 1, 2021
Results First Posted
September 19, 2018
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share